Role of chemokines in tumor growth D Raman, PJ Baugher, YM Thu, A Richmond Cancer letters 256 (2), 137-165, 2007 | 756 | 2007 |
Chemokines in health and disease D Raman, T Sobolik-Delmaire, A Richmond Experimental cell research 317 (5), 575-589, 2011 | 473 | 2011 |
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium M Ao, OE Franco, D Park, D Raman, K Williams, SW Hayward Cancer research 67 (9), 4244-4253, 2007 | 335 | 2007 |
Crystal structure of cone arrestin at 2.3 Å: evolution of receptor specificity RB Sutton, SA Vishnivetskiy, J Robert, SM Hanson, D Raman, BE Knox, ... Journal of molecular biology 354 (5), 1069-1080, 2005 | 208 | 2005 |
Regulation of arrestin binding by rhodopsin phosphorylation level SA Vishnivetskiy, D Raman, J Wei, MJ Kennedy, JB Hurley, VV Gurevich Journal of Biological Chemistry 282 (44), 32075-32083, 2007 | 182 | 2007 |
Visual and both non-visual arrestins in their “inactive” conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm X Song, D Raman, EV Gurevich, SA Vishnivetskiy, VV Gurevich Journal of Biological Chemistry 281 (30), 21491-21499, 2006 | 150 | 2006 |
Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity SM Hanson, WM Cleghorn, DJ Francis, SA Vishnivetskiy, D Raman, ... Journal of molecular biology 368 (2), 375-387, 2007 | 142 | 2007 |
The cloning of GRK7, a candidate cone opsin kinase, from cone-and rod-dominant mammalian retinas ER Weiss, D Raman, S Shirakawa, MH Ducceschi, PT Bertram, F Wong, ... Mol Vis 4 (27), 865-885, 1998 | 127 | 1998 |
Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis J Sai, D Raman, Y Liu, J Wikswo, A Richmond Journal of biological chemistry 283 (39), 26538-26547, 2008 | 84 | 2008 |
VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis NF Neel, M Barzik, D Raman, T Sobolik-Delmaire, J Sai, AJ Ham, ... Journal of cell science 122 (11), 1882-1894, 2009 | 79 | 2009 |
Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment AE Vilgelm, CA Johnson, N Prasad, J Yang, SC Chen, GD Ayers, ... Journal of the National Cancer Institute 108 (6), djv406, 2016 | 77 | 2016 |
LIM and SH3 protein-1 modulates CXCR2-mediated cell migration D Raman, J Sai, NF Neel, CS Chew, A Richmond PloS one 5 (4), e10050, 2010 | 77 | 2010 |
Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells Y Ueda, NF Neel, E Schutyser, D Raman, A Richmond Cancer research 66 (11), 5665-5675, 2006 | 72 | 2006 |
Binding of arrestin to cytoplasmic loop mutants of bovine rhodopsin D Raman, S Osawa, ER Weiss Biochemistry 38 (16), 5117-5123, 1999 | 53 | 1999 |
Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal W Shi, CD Sports, D Raman, S Shirakawa, S Osawa, ER Weiss Biochemistry 37 (14), 4869-4874, 1998 | 53 | 1998 |
New frontiers for the cytoskeletal protein LASP1 E Butt, D Raman Frontiers in oncology 8, 391, 2018 | 52 | 2018 |
LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex N Duvall-Noelle, A Karwandyar, A Richmond, D Raman Oncogene 35 (9), 1122-1133, 2016 | 49 | 2016 |
The interaction with the cytoplasmic loops of rhodopsin plays a crucial role in arrestin activation and binding D Raman, S Osawa, VV Gurevich, ER Weiss Journal of neurochemistry 84 (5), 1040-1050, 2003 | 45 | 2003 |
Novel and alternative targets against breast cancer stemness to combat chemoresistance S Sridharan, CM Howard, AMC Tilley, B Subramaniyan, AK Tiwari, ... Frontiers in Oncology 9, 1003, 2019 | 44 | 2019 |
Targeting of the eukaryotic translation initiation factor 4A against breast cancer stemness S Sridharan, M Robeson, D Bastihalli-Tukaramrao, CM Howard, ... Frontiers in Oncology 9, 1311, 2019 | 38 | 2019 |